Skip to main content

July Update: Psychedelic Compounds-Based Drug Stocks Index Up 23%; Remains Down 44% YTD

Of the 107 clinical-stage psychedelic drug stocks trading on North American stock exchanges only 8 have market caps of $50M or more, and trade for US$0.50/share or more.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.